Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is one of the best strong buy stocks to invest in under $5. Needham maintained a bullish outlook on Taysha Gene Therapies, Inc. (NASDAQ:TSHA) on January 6, reiterating a Buy rating on the stock with a$10 price target. The rating update came the same day Taysha Gene Therapies, Inc. (NASDAQ:TSHA) announced the dosing of the first patient in the REVEAL pivotal trial evaluating TSHA-102 in Q4 2025, with enrollment advancing across multiple sites. It reported progress ...